TE_8327

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family SVA_B
TE superfamily SVA
TE class Retroposon
Gene -, FHIT
Class Chimeric, Intergenic
Coding Annoated, Non-coding
Tumor-specific score 160.05
Counts of samples TCGA_tumor:141; TCGA_normal:0; GTEx:0
TSS chr3(-):61435007



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_8327.11 FHIT Chimeric Annoated MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTFSMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ* chr3(-):59749548,59749568,59752221,59752321,59922346,59922414,60011371,60011400,60014007,60014152,60536860,60536979,60821919,60822011,61042047,61042099,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008
teRNA_8327.12 FHIT Chimeric Non-coding Non-coding chr3(-):59752301,59752321,59922346,59922414,60011371,60011400,60014007,60014152,60536860,60536979,60821919,60822011,61042047,61042099,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008
teRNA_8327.13 FHIT Chimeric Non-coding Non-coding chr3(-):60014132,60014152,60536860,60536979,60765524,60765563,60821919,60822011,61042047,61042099,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008
teRNA_8327.14 FHIT Chimeric Non-coding Non-coding chr3(-):60536959,60536979,60821919,60822011,61165575,61165828,61166973,61167042,61200617,61200665,61284618,61284664,61315372,61315482,61317816,61317939,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008
teRNA_8327.15 - Intergenic Non-coding Non-coding chr3(-):61383295,61383315,61405453,61405505,61425745,61425874,61428514,61428635,61429160,61429307,61434924,61435008


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).